Transsexualism Clinical Trial
Official title:
HPV Prevalence in Transpersons - a Prospective Study
NCT number | NCT04864951 |
Other study ID # | 1186/2021 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 2, 2021 |
Est. completion date | November 1, 2021 |
Verified date | March 2023 |
Source | Medical University of Vienna |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In this study, Human Papilloma Virus (HPV) prevalence will be determined once in the urine of 200 trans people. In addition, subjects will be asked to complete a questionnaire about their sexual orientation, which is adapted from the largest published study.
Status | Completed |
Enrollment | 203 |
Est. completion date | November 1, 2021 |
Est. primary completion date | November 1, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Transpeople - Age over 18 years - Sufficient knowledge of German Exclusion Criteria: - Age under 18 years - Insufficient knowledge of German |
Country | Name | City | State |
---|---|---|---|
Austria | Medical University of Vienna | Vienna | |
Slovenia | Institute of Microbiology and Immunology Faculty of Medicine | Ljubljana |
Lead Sponsor | Collaborator |
---|---|
Sophie Pils |
Austria, Slovenia,
Reisner SL, Deutsch MB, Peitzmeier SM, White Hughto JM, Cavanaugh TP, Pardee DJ, McLean SA, Panther LA, Gelman M, Mimiaga MJ, Potter JE. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients. PLoS One. 2018 Mar 14;13(3):e0190172. doi: 10.1371/journal.pone.0190172. eCollection 2018. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | HPV prevalence in transpeople | HPV prevalence in transpeople | one year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05487794 -
Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men With Erythrocytosis
|
N/A | |
Completed |
NCT02185274 -
Observational Study on Metabolism and Psychopathology in Transsexual Patients
|
||
Recruiting |
NCT04838249 -
Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
|
||
Completed |
NCT00146146 -
Testosterone and Its Metabolites in GID
|
Phase 3 | |
Completed |
NCT04290286 -
i2TransHealth: Interdisciplinary, Internet-based Trans Health Care
|
N/A | |
Completed |
NCT00435513 -
A Common Polymorphism of the SRD5A2 Gene is Not Associated With Male-to-Female and Female-to-Male Transsexualism
|
Phase 0 | |
Recruiting |
NCT03637920 -
Sexuality in Transmen During Hormone and Operative Treatment
|
||
Completed |
NCT03823014 -
Use of an External Erectile Device in Transgender Man Following Phalloplasty
|
N/A | |
Recruiting |
NCT03872648 -
TransCare - Genital Surgery for Trans Women in Centralized vs. Decentralized Health Care Delivery Settings
|
||
Completed |
NCT01065220 -
Sex Steroids and the Serotonin Transporter
|
Phase 4 | |
Enrolling by invitation |
NCT03595956 -
Transgender Cohort Study of Gender Affirmation and HIV-related Health
|
||
Completed |
NCT02119377 -
First Australian National Trans Mental Health Study
|
N/A | |
Completed |
NCT02518009 -
GEnder Dysphoria Treatment in Sweden
|
||
Completed |
NCT00135148 -
Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group
|
N/A |